Published in Ophthalmology on January 22, 2009
Ranibizumab and Bevacizumab for Diabetic Macular Edema | NCT01610557
Prevalence of and risk factors for diabetic macular edema in the United States. JAMA Ophthalmol (2014) 1.74
Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol (2010) 1.61
Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema. Diabetes (2015) 1.45
The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol (2012) 1.45
Adaptive optics technology for high-resolution retinal imaging. Sensors (Basel) (2012) 1.30
Are individuals with diabetes seeing better?: a long-term epidemiological perspective. Diabetes (2010) 1.23
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond) (2015) 1.14
Adaptive optics retinal imaging--clinical opportunities and challenges. Curr Eye Res (2013) 1.12
Managing diabetic macular edema: The leading cause of diabetes blindness. World J Diabetes (2011) 1.08
Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far. Mol Vis (2011) 1.05
Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability. J Ophthalmol (2011) 1.02
Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser. Clin Ophthalmol (2013) 1.02
Current treatments in diabetic macular oedema: systematic review and meta-analysis. BMJ Open (2013) 1.00
Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care (2012) 0.99
GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence. Diabetologia (2014) 0.97
Epidemiological issues in diabetic retinopathy. Middle East Afr J Ophthalmol (2013) 0.97
The prevalence of type 1 diabetes in the United States. Epidemiology (2013) 0.97
Prevalence, Demographics, and Treatment Characteristics of Visual Impairment due to Diabetic Macular Edema in a Representative Canadian Cohort. J Ophthalmol (2012) 0.96
Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci (2014) 0.95
Current trends in the monitoring and treatment of diabetic retinopathy in young adults. Mediators Inflamm (2014) 0.95
Cigarette smoking as a risk factor for uveitis. Ophthalmology (2009) 0.90
Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema. Drug Des Devel Ther (2013) 0.89
Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: a meta-analysis. Int J Ophthalmol (2013) 0.89
Ten-year cumulative incidence of diabetic retinopathy. The Beijing Eye Study 2001/2011. PLoS One (2014) 0.88
Cost-effectiveness of treatment of diabetic macular edema. Ann Intern Med (2014) 0.88
Prediction, by retinal location, of the onset of diabetic edema in patients with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci (2011) 0.87
Recent developments in laser treatment of diabetic retinopathy. Middle East Afr J Ophthalmol (2015) 0.86
Emerging pharmacotherapies for diabetic macular edema. Exp Diabetes Res (2012) 0.86
Current concepts in diabetic retinopathy. Diabetes Metab J (2014) 0.84
Current status in diabetic macular edema treatments. World J Diabetes (2013) 0.83
Diabetic retinopathy is associated with oxidative stress and mitigation of gene expression of antioxidant enzymes. Int J Gen Med (2013) 0.82
Hospitalized cardiovascular events in patients with diabetic macular edema. BMC Ophthalmol (2012) 0.81
Prognostic significance of foveal capillary drop-out and previous panretinal photocoagulation for diabetic macular oedema treated with ranibizumab. Br J Ophthalmol (2015) 0.81
Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice. Stem Cell Res Ther (2016) 0.80
Impact of changes in metabolic control on progression to photocoagulation for clinically significant macular oedema: a 20 year study of type 1 diabetes. Diabetologia (2013) 0.78
Predictors of adherence with self-care guidelines among persons with type 2 diabetes: results from a logistic regression tree analysis. J Behav Med (2011) 0.78
[Diabetic maculopathy and retinopathy. Functional and sociomedical significance]. Ophthalmologe (2010) 0.77
Combination therapy for diabetic macular edema. J Ophthalmol (2012) 0.77
Impact of Lycium Barbarum Polysaccharide and Danshensu on vascular endothelial growth factor in the process of retinal neovascularization of rabbit. Int J Ophthalmol (2013) 0.77
Advances in the management of diabetic macular oedema based on evidence from the Diabetic Retinopathy Clinical Research Network. Singapore Med J (2015) 0.76
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy. Int J Mol Sci (2016) 0.76
Role of SLMAP genetic variants in susceptibility of diabetes and diabetic retinopathy in Qatari population. J Transl Med (2015) 0.76
Corticosteroid Treatment in Diabetic Macular Edema. Turk J Ophthalmol (2017) 0.75
Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant. Diabetes Metab Syndr Obes (2015) 0.75
Association Between Diabetic Macular Edema and Cardiovascular Events in Type 2 Diabetes Patients: A Multicenter Observational Study. Medicine (Baltimore) (2015) 0.75
Diabetic macular edema. Saudi J Ophthalmol (2009) 0.75
Baseline predictors of visual acuity and retinal thickness in patients with retinal vein occlusion. J Korean Med Sci (2015) 0.75
Fingolimod Associated Bilateral Cystoid Macular Edema-Wait and See? Int J Mol Sci (2016) 0.75
Impact of data from recent clinical trials on strategies for treating patients with type 2 diabetes mellitus. Vasc Health Risk Manag (2010) 0.75
Reversible retinal vessel closure from VEGF-induced leukocyte plugging. JCI Insight (2017) 0.75
Semi-automated quantification of hard exudates in colour fundus photographs diagnosed with diabetic retinopathy. BMC Ophthalmol (2017) 0.75
Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseases. Graefes Arch Clin Exp Ophthalmol (2017) 0.75
Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med (1999) 22.81
Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology (1991) 11.37
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med (2000) 10.05
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (1984) 9.28
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol (1984) 7.68
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology (1991) 7.27
Is glycemic control improving in U.S. adults? Diabetes Care (2007) 5.30
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology (1998) 4.21
Systemic effects of smoking. Chest (2007) 3.63
The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group. Prev Med (1976) 3.57
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology (2008) 3.37
The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol (1994) 3.24
A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med (1995) 3.17
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care (2003) 3.12
An alternative method of grading diabetic retinopathy. Ophthalmology (1986) 3.05
Ten-year incidence of visual loss in a diabetic population. Ophthalmology (1994) 2.91
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology (1995) 2.70
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (1989) 2.59
Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye (Lond) (2004) 2.54
The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology (1989) 2.51
Carbon monoxide and human health. Science (1968) 2.50
Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol (2002) 2.12
The changing epidemiology of diabetic microangiopathy in type 1 diabetes. Diabetologia (2005) 2.06
Diabetic retinopathy. Assessment of severity and progression. Ophthalmology (1984) 2.05
A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes (2004) 2.03
Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med (2004) 1.89
A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes (1980) 1.57
Prevalence of diabetes mellitus in southern Wisconsin. Am J Epidemiol (1984) 1.56
Prevalence of diabetic complications in relation to risk factors. Diabetes (1986) 1.51
Smoking, platelets and thrombosis. Nature (1972) 1.28
The evolution and natural history of diabetic retinopathy. Int Ophthalmol Clin (1978) 1.21
The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology (1993) 1.10
Clinically significant macular edema and survival in type 1 and type 2 diabetes. Am J Ophthalmol (2008) 1.06
The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes. Diabetes Care (2001) 1.04
Cigarette smoking and ten-year progression of diabetic retinopathy. Ophthalmology (1996) 1.03
Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study. J Diabetes Complications (2007) 1.00
Is cigarette smoking associated with diabetic retinopathy? Am J Epidemiol (1983) 0.99
Association of cigarette smoking with diabetic retinopathy. Diabetes Care (1991) 0.99
The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol (1991) 0.99
Nine-year incidence of diabetic retinopathy in the Barbados Eye Studies. Arch Ophthalmol (2006) 0.98
Methodologic considerations in measuring glycosylated hemoglobin in epidemiologic studies. J Clin Epidemiol (1988) 0.97
Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy? Ophthalmology (1993) 0.97
Six-year progression of retinopathy and associated risk factors in African American patients with type 1 diabetes mellitus: the New Jersey 725. Arch Ophthalmol (2006) 0.96
Risk factors for diffuse and focal macular edema. J Diabetes Complications (2004) 0.96
Diabetic retinopathy in Joslin Clinic patients with adult-onset diabetes. Ophthalmology (1981) 0.94
Clinically significant macular edema in type I diabetes. Incidence and risk factors. Ophthalmology (1995) 0.88
Diabetic macular edema in juvenile- and adult-onset diabetes. Am J Ophthalmol (1980) 0.85
Incidence and progression of diabetic retinopathy in an Aboriginal Australian population: results from the Katherine Region Diabetic Retinopathy Study (KRDRS). Report no. 2. Clin Experiment Ophthalmol (2005) 0.83
Prevalence of diabetic retinopathy. A population study from the Swedish island of Gotland. Acta Ophthalmol Suppl (1988) 0.78
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol (2006) 4.68
The prevalence of refractive errors among adults in the United States, Western Europe, and Australia. Arch Ophthalmol (2004) 4.64
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol (2005) 4.46
Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA (2010) 4.41
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30
Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology (2007) 3.96
The impact of hearing loss on quality of life in older adults. Gerontologist (2003) 3.87
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology (2002) 3.80
Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol (2004) 3.78
Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology (2004) 3.53
Revised formulas for summarizing retinal vessel diameters. Curr Eye Res (2003) 3.47
Prevalence of olfactory impairment in older adults. JAMA (2002) 3.46
Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet (2008) 3.42
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology (2008) 3.37
The 5-year incidence and progression of hearing loss: the epidemiology of hearing loss study. Arch Otolaryngol Head Neck Surg (2003) 3.17
Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology (2006) 2.95
Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet (2003) 2.92
The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol (2006) 2.89
Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol (2011) 2.89
Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis Sci (2006) 2.79
Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA (2002) 2.78
Human rhinovirus species and season of infection determine illness severity. Am J Respir Crit Care Med (2012) 2.77
Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study. Am J Ophthalmol (2006) 2.77
Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA (2002) 2.72
Long-term use of aspirin and age-related macular degeneration. JAMA (2012) 2.72
Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care (2002) 2.70
Detection of age-related macular degeneration using a nonmydriatic digital camera and a standard film fundus camera. Arch Ophthalmol (2004) 2.67
The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology (2003) 2.49
Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet (2013) 2.36
Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet (2005) 2.34
Validity of the alcohol use disorders identification test in college students. Alcohol Clin Exp Res (2004) 2.30
Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology (2004) 2.26
Detecting disease-causing genes by LASSO-Patternsearch algorithm. BMC Proc (2007) 2.25
The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol (2008) 2.24
Generational differences in the prevalence of hearing impairment in older adults. Am J Epidemiol (2009) 2.18
Retinal arteriolar diameter and risk for hypertension. Ann Intern Med (2004) 2.18
Enduring effects of prenatal and infancy home visiting by nurses on children: follow-up of a randomized trial among children at age 12 years. Arch Pediatr Adolesc Med (2010) 2.18
Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol (2004) 2.16
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet (2010) 2.15
Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ (2004) 2.10
Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology (2007) 2.07
Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology (2003) 2.04
The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol (2004) 2.03
Retinal microvascular abnormalities and risk of lacunar stroke: Atherosclerosis Risk in Communities Study. Stroke (2010) 1.91
Are inflammatory factors related to retinal vessel caliber? The Beaver Dam Eye Study. Arch Ophthalmol (2006) 1.89
Developmental cytokine response profiles and the clinical and immunologic expression of atopy during the first year of life. J Allergy Clin Immunol (2003) 1.89
Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med (2004) 1.89
Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophthalmol (2008) 1.89
Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am J Epidemiol (2002) 1.87
Retinal vascular caliber in persons with type 2 diabetes: the Wisconsin Epidemiological Study of Diabetic Retinopathy: XX. Ophthalmology (2006) 1.83
Aortic distensibility and retinal arteriolar narrowing: the multi-ethnic study of atherosclerosis. Hypertension (2007) 1.83
EPHA2 is associated with age-related cortical cataract in mice and humans. PLoS Genet (2009) 1.82
Refractive errors, intraocular pressure, and glaucoma in a white population. Ophthalmology (2003) 1.81
Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. J Allergy Clin Immunol (2005) 1.81
Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA (2002) 1.80
Genome-wide linkage study of retinal vessel diameters in the Beaver Dam Eye Study. Hypertension (2006) 1.80
Identification of novel genetic loci for intraocular pressure: a genomewide scan of the Beaver Dam Eye Study. Arch Ophthalmol (2007) 1.79
The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol (2010) 1.78
Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke (2002) 1.77
The prevalence of hearing impairment and associated risk factors: the Beaver Dam Offspring Study. Arch Otolaryngol Head Neck Surg (2011) 1.76
Frailty, morbidity and survival. Arch Gerontol Geriatr (2005) 1.75
Incidence of dry eye in an older population. Arch Ophthalmol (2004) 1.74
Statin use and the five-year incidence and progression of age-related macular degeneration. Am J Ophthalmol (2007) 1.73
The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study. Ophthalmology (2002) 1.73
Relationship between white blood cell count and incident hypertension. Am J Hypertens (2004) 1.73
Decreased lung function after preschool wheezing rhinovirus illnesses in children at risk to develop asthma. J Allergy Clin Immunol (2011) 1.73
Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25. Ophthalmology (2008) 1.69
Retinal vessel diameters and their associations with age and blood pressure. Invest Ophthalmol Vis Sci (2003) 1.69
Examining the relative influence of familial, genetic, and environmental covariate information in flexible risk models. Proc Natl Acad Sci U S A (2009) 1.68
Socioeconomic status and subclinical atherosclerosis in older adults. Prev Med (2010) 1.67
Relationship of retinal vascular caliber with diabetes and retinopathy: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care (2007) 1.66
Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations. Eur Heart J (2007) 1.65
Retinal and cerebral microvascular signs and diabetes: the age, gene/environment susceptibility-Reykjavik study. Diabetes (2008) 1.62
Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol (2009) 1.60
Air Pollution and the microvasculature: a cross-sectional assessment of in vivo retinal images in the population-based multi-ethnic study of atherosclerosis (MESA). PLoS Med (2010) 1.59